Challenges of evaluating the cardiac effects of anticancer agents

被引：32

作者：

Bates, Susan E.

Rosing, Douglas R.

Fojo, Tito

Piekarz, Richard L.

机构：

[1] NCI, Med Oncol Branch, Bethesda, MD 20892 USA

[2] NHLBI, Bethesda, MD 20892 USA

来源：

CLINICAL CANCER RESEARCH | 2006年 / 12卷 / 13期

关键词：

D O I：

10.1158/1078-0432.CCR-06-1017

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：3871 / 3874

页数：4

共 31 条

[1]

BECK J, 2005, P AM SOC CLIN ONC, V23

[2]

De Ponti F, 2002, DRUG SAFETY, V25, P263

[3]

DUVIC M, 2005, P AM SOC CLIN ONC, V23

[4] Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist -: Results of a phase III, single-dose trial versus dolasetron [J].

Eisenberg, P ;

Figueroa-Vadillo, J ;

Zamora, R ;

Charu, V ;

Hajdenberg, J ;

Cartmell, A ;

Macciocchi, A ;

Grunberg, S .

CANCER, 2003, 98 (11) :2473-2482

[5] Sudden adult death syndrome and other non-ischaemic causes of sudden cardiac death [J].

Fabre, A ;

Sheppard, MN .

HEART, 2006, 92 (03) :316-320

[6]

FISCHER T, 2005, P AM SOC CLIN ONC, V23

[7] Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron [J].

Gralla, R ;

Lichinitser, M ;

Van der Vegt, S ;

Sleeboom, H ;

Mezger, J ;

Peschel, C ;

Tonini, G ;

Labianca, R ;

Macciocchi, A ;

Aapro, M .

ANNALS OF ONCOLOGY, 2003, 14 (10) :1570-1577

[8] Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer [J].

Kelly, WK ;

O'Connor, OA ;

Krug, LM ;

Chiao, JH ;

Heaney, M ;

Curley, T ;

MacGregore-Cortelli, B ;

Tong, W ;

Secrist, JP ;

Schwartz, L ;

Richardson, S ;

Chu, E ;

Olgac, S ;

Marks, PA ;

Scher, H ;

Richon, VM .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (17) :3923-3931

[9]

Kelly WK, 2003, CLIN CANCER RES, V9, P3578

[10] Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer [J].

Minucci, S ;

Pelicci, PG .

NATURE REVIEWS CANCER, 2006, 6 (01) :38-51

← 1 2 3 4 →